|
Volumn 59, Issue 10, 2011, Pages 970-977
|
[Interpretation of hemostatic and fibrinolytic markers].
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
BENZIMIDAZOLE DERIVATIVE;
BETA ALANINE;
BIOLOGICAL MARKER;
BLOOD CLOTTING FACTOR;
DRUG DERIVATIVE;
FIBRIN DEGRADATION PRODUCT;
N ((2 (((4 (AMINOIMINOMETHYL)PHENYL)AMINO)METHYL) 1 METHYL 1H BENZIMIDAZOL 5 YL)CARBONYL) N 2 PYRIDINYL BETA ALANINE;
N-((2-(((4-(AMINOIMINOMETHYL)PHENYL)AMINO)METHYL)-1-METHYL-1H-BENZIMIDAZOL-5-YL)CARBONYL)-N-2-PYRIDINYL-BETA-ALANINE;
PLASMINOGEN ACTIVATOR;
THROMBOMODULIN;
WARFARIN;
BLOOD;
BLOOD CLOTTING DISORDER;
FIBRINOLYSIS;
HEMOSTASIS;
HUMAN;
PARTIAL THROMBOPLASTIN TIME;
PATHOPHYSIOLOGY;
PROTHROMBIN TIME;
REVIEW;
THROMBOCYTE;
ANTICOAGULANTS;
BENZIMIDAZOLES;
BETA-ALANINE;
BIOLOGICAL MARKERS;
BLOOD COAGULATION DISORDERS;
BLOOD COAGULATION FACTORS;
BLOOD PLATELETS;
FIBRIN FIBRINOGEN DEGRADATION PRODUCTS;
FIBRINOLYSIS;
HEMOSTASIS;
HUMANS;
PARTIAL THROMBOPLASTIN TIME;
PLASMINOGEN ACTIVATORS;
PROTHROMBIN TIME;
THROMBOMODULIN;
WARFARIN;
|
EID: 84856589040
PISSN: 00471860
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (9)
|
References (0)
|